The Sensydia Cardiac Performance System (CPS) is the only hemodynamic monitoring platform that is trained to gold-standard accuracy in a non-invasive system. This clinical breakthrough is enabled by proprietary sensor design, advanced signal processing, and machine learning.| Sensydia
Completion of this 50-subject study is a key milestone on the path to delivering the first device for non-invasive and accurate...| Sensydia
Sensydia has completed a development study of its Cardiac Performance System device to detect pulmonary hypertension and heart failure.| Pulmonary Hypertension News
Sensydia reports completing a 5th study supporting algorithms for its Cardiac Performance System to quickly detect pulmonary hypertension.| Pulmonary Hypertension News
Supporters will unite on May 5 to mark World Pulmonary Hypertension Day, with a focus this year on early diagnosis.| Pulmonary Hypertension News
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto...| Pulmonary Hypertension News
Read about the methods and difficulties to diagnose the lung disease pulmonary hypertension (PH).| Pulmonary Hypertension News
Category archive page for News.| Pulmonary Hypertension News
Lindsey Shapiro is a science writer for Pulmonary Hypertension News with a PhD in neuroscience. She covers the latest news and information on a variety of pulmonary hypertension topics.| Pulmonary Hypertension News
Cereno Scientific reported a successful meeting with the FDA on the design of a future clinical trial for its PAH therapy candidate CS1.| Pulmonary Hypertension News
Pulmonary hypertension (PH) is a chronic and progressive disease associated with high blood pressure in the blood vessels that supply the lungs, known as the pulmonary arteries. Read more about PH here.| Pulmonary Hypertension News
